semaglutide hepatotoxicity A phase 3 trial reported in Nature Medicine shows weekly subcutaneous injections of survodutide, a glucagon receptor/GLP-1R dual agonist, lowered liver fat content and body weight in adults with obesity and at-risk Semaglutide in MASH with F2-F3

10.1016/j.bbr.2010.07.016 Behav

By supporting neurotransmitter activity and cellular health, MIC injections help ease stress and anxiety, promoting a naturally stable mood and sustained energy without the crash associated with stimulants

Emerging therapies focus on optimising brain oxygenation, reducing neuroinflammation and supporting cellular energy production

But what kind of weight is being lost, how sustainable it is, and what happens after the medication is stopped is where the conversation becomes far more complex and far more concerning

The Role of Personalized Support Navigating side effects like thirst is much easier when you have a dedicated team supporting you

Medical perspective Probiotics work best when a healthcare professional sees a need (not everyone will benefit from a probiotic and they can be harmful for some) and are taken alongside healthful lifestyle changes